BRCA1 and RAD51C Promoter Hypermethylation Confer Sensitivity to PARP Inhibitors in Patients with Platinum Sensitive Ovarian Carcinoma

Swisher, E; Harrell, MI; Lin, KK; Scott, CL; Goble, S; Oza, A; Coleman, RL; Swisher, E; Harrell, MI; Lin, KK; Scott, CL; Goble, S; Oza, A; Coleman, RL; Konecny, G; Tinker, AV; O'Malley, DM; Kristeleit, RS; Ma, L; Brenton, J; Bell-McGuinn, K; Oaknin, A; Leary, A; Mann, E; Giordano, H; Raponi, M; McNeish, I; Kaufmann, S; - view fewer (2017) BRCA1 and RAD51C Promoter Hypermethylation Confer Sensitivity to PARP Inhibitors in Patients with Platinum Sensitive Ovarian Carcinoma. Clinical Cancer Research , 23 (11 Suppl) 10.1158/1557-3265.OVCASYMP16-AP28 .

http://ift.tt/2toCHUw